Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790MSha Zhao, Xuefei Li, Chao Zhao, et al.Frontiers in Oncology|March 29, 2021
Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLCSangtian Liu, Fengying Wu, Xuefei Li, et al.Journal of Cellular and Molecular Medicine|January 3, 2020
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathwayXiaozhen Liu, Tao Jiang, Xuefei Li, et al.Oncology Letters|November 23, 2017
Characterization of distinct types of <i>KRAS</i> mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancerYijun Jia, Tao Jiang, Xuefei Li, et al.Cancer Immunology Research|February 14, 2019
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerSha Zhao, Shengxiang Ren, Tao Jiang, et al.Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancerXiaozhen Liu, Tao Jiang, Wei Li, et al.Translational Lung Cancer Research|September 21, 2020
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitorsSangtian Liu, Fei Zhou, Zhiyu Liu, et al.Signal Transduction and Targeted Therapy|June 16, 2026
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trialYi Pan, Xuening Yang, Qing Zhou, et al.Pageof 5